Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: A radiobiological analysis of a randomised clinical trial

Radiotherapy and Oncology

Volumn 70, Issue 1, 2004, Pages 63-74

  Roberts, Stephen A ^a   Hendry, Jolyon H ^b,c   Swindell, Richard ^b   Wilkinson, John M ^b   Hunter, Robin D ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

Brachytherapy; Cervical cancer; Linear quadratic model; Low dose rate; Sublethal damage repair rate; Ratio

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENTEROPATHY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LINEAR REGRESSION ANALYSIS; LOW ENERGY RADIATION; MODEL; MORBIDITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RADIATION DOSE; RADIOBIOLOGY; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM; URINARY TRACT DISEASE; UTERINE CERVIX CARCINOMA;

EID: 0842303362     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.11.010     Document Type: Article

References (36)

1. Bentzen S.M. Dose response relationships in radiotherapy. Steel G.G. Basic clinical radiobiology. 1997;78-86 Arnold, London.
2. Bentzen S.M., Saunders M.I., Dische S. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother Oncol. 53:(3):1999;219-226.
3. Chassagne D., Sismondi P., Horiot J.C., et al. A glossary for reporting complications of treatment in gynaecological cancers. Radiother Oncol. 26:1993;195-202.
4. Cole M. Radiotherapy for cervical cancer-X-rays. Easso E.C. Cancer of the uterine cervix. 1973;53-75 WB Saunders, London.
5. Davidson S.E., West C.M.L., Roberts S.A., Hendry J.H., Hunter R.D. Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour hererogeneity. Radiother Oncol. 18:1990;349-356.
6. Dorr W., Hendry J.H. Consequential late effects in normal tissues. Radiother Oncol. 61:(3):2001;223-231.
7. Ellis F. Dose time fractionation in radiotherapy. Ebert M., Howard A. Current topics in radiation research. 1968;359-397 North-Holland, Amsterdam.
8. Fyles A., Keane T.J., Barton M., Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 25:(4):1992;273-279.
9. Haie-Meder C., Kramer A., Lambin P., Scalliet P., Bouzy J., Gerbaulet A. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys. 29:(5):1994;953-960.
10. Hall E.J., Rossi H.H., Roizin L.A. Low dose-rate irradiation of mammalian cells with radium and californium-252; a comparison of effects on an actively proliferating cell population. Radiology. 99:1971;445-451.
11. Hunter R.D. Female genital tract. Pointon R.C.S. The radiotherapy of malignant disease. 1991;279-308 Springer, London.
12. Hunter R.D. Dose rate correction in LDR intracavity therapy. Mould R.F., Butterman J.J., Speiser B.L. Brachytherapy from radium to optimisation. 1994;55-59 Nucletron International BV, The Netherlands.
13. Hunter R.D. Editorial. Radiother Oncol. 39:1996;95-96.
14. Hunter R.D., Davidson S.E. Low-dose-rate brachytherapy for treating cervix carcinoma: changing dose-rate. Joslin C., Flynn A., Hall E.J. Principles and practice of brachytherapy. 2002;343-353 Arnold, London.
15. Jones D.A., Notley H.M., Hunter R.D. Geometry adopted by Manchester radium applicators and Selectron afterloading applicators in intracavitary treatment for carcinoma cervix uteri. Br J Radiol. 60:1987;481-486.
16. Lanciano R.M., Martz K., Coia L., Hanks G.E. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys. 20:(1):1991;95-100.
17. Leborgne F., Fowler J.F., Leborgne J.H., Zubizarreta E., Curochquin R. Medium-dose-rate brachytherapy of cancer of the cervix: preliminary results of a prospectively designed schedule based on the linear-quadratic model. Int J Radiat Oncol Biol Phys. 43:(5):1999;1061-1064.
18. Mazeron J.J., Simon J.M., Crook J.M., et al. Influence of dose rate on local control of breast carcinoma treated by external beam irradiation plus iridium 192 implant. Int J Radiat Oncol Biol Phys. 21:(5):1991;1173-1177.
19. Mazeron J.J., Simon J.M., Le Pechoux C., et al. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192. Radiother Oncol. 21:(1):1991;39-47.
20. Millar W.T., Hendry J.H., Canney P.A. The influence of the number of fractions and bi-exponential repair kinetics on biological equivalence in pulsed brachytherapy. Br J Radiol. 69:1996;457-468.
21. Moore J.V., Hendry J.H., Hunter R.D. Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells. Radiother Oncol. 1:(2):1983;143-157.
22. Newman G. Increased morbidity following the introduction of remote afterloading, with increased dose rate, for cancer of the cervix. Radiother Oncol. 39:1996;97-103.
23. Nori D., Dasari N., Allbright R.M. Gynecologic brachytherapy I: proper incorporation of brachytherapy into the current multimodality management of carcinoma of the cervix. Semin Radiat Oncol. 12:(1):2002;40-52.
24. Patel F.D., Negi P.S., Sharma S.C., Kapoor R., Singh D.P., Ghoshal S. Dose rate correction in medium dose rate brachytherapy for carcinoma cervix. Radiother Oncol. 49:1998;317-323.
25. Paterson R. Studies in optimum dosage. Br J Radiol. 25:1952;505-516.
26. Paterson R. The treatment of malignant disease by radiotherapy. 2nd ed. 1963;Arnold, London.
27. Perez C.A., Grigsby P.W., Castro-Vita H., Lockett M.A. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 32:(5):1995;1275-1288.
28. Petereit D.G., Sarkaria J.N., Chappell R., et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 32:(5):1995;1301-1307.
29. Roberts S.A., Hendry J.H. A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity. Int J Radiat Oncol Biol Phys. 41:1998;689-699.
30. Rodrigus P., De Winter K., Venselaar J.L., Leers W.H. Evaluation of late morbidity in patients with carcinoma of the uterine cervix following a dose rate change. Radiother Oncol. 42:(2):1997;137-141.
31. S-Plus 2000. Release 3. Insightful Corp, Seattle, WA, USA; 2000.
32. Stout R., Hunter R.D. Clinical trials of changing dose rate in intracavity low dose rate therapy. Mould R.F. Brachytherapy 2. 1989;219-222 Nucletron International BV, The Netherlands.
33. Taylor J.M., Kim D.K. Statistical models for analysing time-to-occurrence data in radiobiology and radiation oncology. Int J Radiat Biol. 64:(5):1993;627-640.
34. Thames H.D. An incomplete repair model for survival after fractionated and continuous irradiations. Int J Radiat Biol. 47:1985;319-339.
35. Tod M.C. The optimum dosage in the treatment of carcinoma of the uterine cervix by radiation. Br J Radiol. 14:1941;23-29.
36. Wilkinson J.M., Hendry J.H., Hunter R.D. Dose-rate considerations in the introduction of low-dose-rate afterloading intracavitary techniques for radiotherapy. Br J Radiol. 53:1980;890-893.